時間 | 主題 | 講者 | 座長 | 摘要 | 簡報 |
---|---|---|---|---|---|
09:00 ~ 09:20 |
瀏覽海報時間 |
All |
李偉嘉, 姜秉均 |
||
09:20 ~ 09:24 |
MP01-01: Can we use urinary biomarkers to identify occult detrusor overactivity in women with stress urinary incontinence? |
陳維心 |
李偉嘉, 姜秉均 |
||
09:24 ~ 09:28 |
MP01-02: Association with female stress urinary incontinence and sarcopenia defined by bioelectrical inpedance analysis |
江長和 |
李偉嘉, 姜秉均 |
||
09:28 ~ 09:32 |
MP01-03: Transvaginal ultrasound shear wave elastography to evaluate detrusor wall of bladder pain syndrome in women: A preliminary report |
瞿琤 |
李偉嘉, 姜秉均 |
||
09:32 ~ 09:36 |
MP01-04: Therapeutic efficacy of biofeedback pelvic floor muscle exercise in women with dysfunctional voiding |
江景翔 |
李偉嘉, 姜秉均 |
||
09:36 ~ 09:40 |
MP01-05: Use cluster analysis to develop an accurate and practical diagnostic method for detrusor underactivity in female patient without bladder outlet obstruction |
陳人傑 |
李偉嘉, 姜秉均 |
||
09:40 ~ 09:44 |
MP01-06: Type D personality is a predictor of worse quality of life in women with non-neurogenic voiding dysfunction |
林巧文 |
李偉嘉, 姜秉均 |
||
09:44 ~ 09:48 |
MP01-07: Therapeutic outcome of active management in male patients with detrusor underactivity based on clinical diagnosis and videourodynamic classification |
劉民慶 |
李偉嘉, 姜秉均 |
||
09:48 ~ 09:52 |
MP01-08: Treatment outcomes of detrusor underactivity in women based on clinical and videourodynamic characteristics |
陳聖復 |
李偉嘉, 姜秉均 |
||
09:52 ~ 09:56 |
MP01-09: Therapeutic efficacy and cognitive adverse events of overactive bladder medication in patients with central nervous system disorders- a cohort study |
張天霖 |
李偉嘉, 姜秉均 |
||
09:56 ~ 10:00 |
MP01-10: Mirabegron is more tolerable than solifenacin in sjogren’s syndrome patients with overactive bladder symptoms |
曾浩翔 |
李偉嘉, 姜秉均 |